{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=105&status=COMPLETED", "query": { "status": "COMPLETED", "page": 105 }, "page_size": 10 }, "pagination": { "page": 105, "page_size": 10, "total_count": 121474, "total_pages": 12148, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=106&status=COMPLETED&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=104&status=COMPLETED&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T09:47:25.270Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05062759", "title": "Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate to Severe Asthma" ], "interventions": [ { "name": "Tezepelumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Years to 21 Years" }, "enrollment_count": 70, "start_date": "2021-08-23", "completion_date": "2022-07-18", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 15, "location_summary": "Bakersfield, California • Huntington Beach, California • Miami, Florida + 12 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Northfield", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05062759" }, { "nct_id": "NCT02508259", "title": "University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Autism Spectrum Disorders" ], "interventions": [ { "name": "Suramin", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "17 Years", "sex": "MALE", "summary": "4 Years to 17 Years · Male only" }, "enrollment_count": 10, "start_date": "2015-05", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02508259" }, { "nct_id": "NCT03214380", "title": "A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "LY900014", "type": "DRUG" }, { "name": "Insulin Lispro", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" }, { "name": "Insulin Degludec", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "SGLT2 inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 933, "start_date": "2017-07-14", "completion_date": "2019-03-13", "has_results": true, "last_update_posted_date": "2020-03-27", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 32, "location_summary": "Fresno, California • La Mesa, California • Lancaster, California + 26 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Clarita", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03214380" }, { "nct_id": "NCT03367962", "title": "Detection of Graft Versus Host Disease With [18F]F-AraG", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "[18F]F-Ara-G", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CellSight Technologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 9, "start_date": "2018-05-15", "completion_date": "2023-10-21", "has_results": true, "last_update_posted_date": "2025-12-08", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03367962" }, { "nct_id": "NCT06064162", "title": "Ketamine for MS Fatigue", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "ketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alta Bates Summit Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2023-12-05", "completion_date": "2025-05-05", "has_results": false, "last_update_posted_date": "2025-06-08", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "Berkeley, California", "locations": [ { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06064162" }, { "nct_id": "NCT04047862", "title": "Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Locally Advanced and Metastatic Solid Tumors" ], "interventions": [ { "name": "Ociperlimab", "type": "DRUG" }, { "name": "Tislelizumab", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Nab paclitaxel", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "5fluorouracil", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BeiGene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 446, "start_date": "2019-08-15", "completion_date": "2024-08-07", "has_results": true, "last_update_posted_date": "2025-08-22", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Fort Myers, Florida • Jacksonville, Florida + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04047862" }, { "nct_id": "NCT01332188", "title": "Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Allergic Conjunctivitis" ], "interventions": [ { "name": "AC-170 0.05%", "type": "DRUG" }, { "name": "AC-170 0.1%", "type": "DRUG" }, { "name": "AC-170 0.24%", "type": "DRUG" }, { "name": "AC-170 0%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aciex Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": null, "sex": "ALL", "summary": "10 Years and older" }, "enrollment_count": 101, "start_date": "2011-04", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2017-08-30", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01332188" }, { "nct_id": "NCT00333203", "title": "Next Generation Ophthalmic Irrigating Solution Posterior Segment Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eye Diseases" ], "interventions": [ { "name": "Next Generation Ophthalmic Irrigating Solution (NGOIS)", "type": "DRUG" }, { "name": "BSS Plus", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 369, "start_date": "2005-10", "completion_date": "2006-03", "has_results": false, "last_update_posted_date": "2012-03-05", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00333203" }, { "nct_id": "NCT01468727", "title": "Study on Use of Xylitol-wipes to Prevent Dental Caries", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dental Caries" ], "interventions": [ { "name": "xylitol wipe", "type": "DIETARY_SUPPLEMENT" }, { "name": "placebo wipe", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "35 Months", "sex": "ALL", "summary": "6 Months to 35 Months" }, "enrollment_count": 88, "start_date": "2007-01", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2011-11-16", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01468727" }, { "nct_id": "NCT00003427", "title": "Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anal Cancer", "Colorectal Cancer", "Esophageal Cancer", "Extrahepatic Bile Duct Cancer", "Gallbladder Cancer", "Gastric Cancer", "Gastrointestinal Carcinoid Tumor", "Liver Cancer", "Pancreatic Cancer", "Small Intestine Cancer" ], "interventions": [ { "name": "irinotecan hydrochloride", "type": "DRUG" }, { "name": "oxaliplatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "1998-04", "completion_date": "2002-04", "has_results": false, "last_update_posted_date": "2013-06-26", "last_synced_at": "2026-11-07T09:47:25.270Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003427" } ] }